1. Sennaroğlu L, Bajin MD. Classification and current management of inner ear malformations. Balkan Med J. 2017; Sep. 34(5):397–411.
Article
2. Schrauwen I, Kari E, Mattox J, Llaci L, Smeeton J, Naymik M, et al. De novo variants in GREB1L areassociated with non-syndromic inner ear malformations and deafness. Hum Genet. 2018; Jul. 137(6-7):459–70.
Article
3. Schrauwen I, Liaqat K, Schatteman I, Bharadwaj T, Nasir A, Acharya A, et al. Autosomal dominantly inherited GREB1L variants in individuals with profound sensorineural hearing impairment. Genes (Basel). 2020; Jun. 11(6):687.
Article
4. De Tomasi L, David P, Humbert C, Silbermann F, Arrondel C, Tores F, et al. Mutations in GREB1L cause bilateral kidney agenesis in humans and mice. Am J Hum Genet. 2017; Nov. 101(5):803–14.
Article
5. Kim BJ, Oh DY, Han JH, Oh J, Kim MY, Park HR, et al. Significant Mendelian genetic contribution to pediatric mild-to-moderate hearing loss and its comprehensive diagnostic approach. Genet Med. 2020; Jun. 22(6):1119–28.
Article
6. Kim BJ, Kim AR, Lee C, Kim SY, Kim NK, Chang MY, et al. Discovery of CDH23 as a significant contributor to progressive postlingual sensorineural hearing loss in Koreans. PLoS One. 2016; Oct. 11(10):e0165680.
Article
7. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; May. 17(5):405–24.
Article
8. Oza AM, DiStefano MT, Hemphill SE, Cushman BJ, Grant AR, Siegert RK, et al. Expert specification of the ACMG/AMP variant interpretation guidelines for genetic hearing loss. Hum Mutat. 2018; Nov. 39(11):1593–613.
Article
9. Kyei Barffour I, Kyei Baah Kwarkoh R. GREB1L as a candidate gene of Mayer-Rokitansky-Küster-Hauser Syndrome. Eur J Med Genet. 2021; Mar. 64(3):104158.
Article
10. Rentzsch P, Schubach M, Shendure J, Kircher M. CADD-Splice-improving genome-wide variant effect prediction using deep learning-derived splice scores. Genome Med. 2021; Feb. 13(1):31.
Article
11. Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016; Oct. 99(4):877–85.
Article
12. Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020; May. 581(7809):434–43.
Article
13. Jung KS, Hong KW, Jo HY, Choi J, Ban HJ, Cho SB, et al. KRGDB: the large-scale variant database of 1722 Koreans based on whole genome sequencing. Database (Oxford). 2020; Jan. 2020:baaa030.
Article